{
    "clinical_study": {
        "@rank": "168346", 
        "acronym": "SPLENDOUR", 
        "arm_group": [
            {
                "arm_group_label": "None, standard chemotherapy only", 
                "arm_group_type": "Other", 
                "description": "4 - 6 cycles of standard chemotherapy + best supportive care.\nStandard chemotherapy consis of a combination of platinum-based agents plus gemcitabine or pemetrexed."
            }, 
            {
                "arm_group_label": "Standard chemotherapy + Denosumab", 
                "arm_group_type": "Experimental", 
                "description": "4 - 6 cycles of standard chemotherapy + denosumab 120 mg, administered subcutaneously every 3-4 weeks.\nStandard chemotherapy consis of a combination of platinum-based agents plus gemcitabine or pemetrexed."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate how well the standard treatment (chemotherapy)\n      in combination with denosumab works compared with the standard treatment alone in patients\n      with a type of lung cancer called \"non small cell lung cancer\" (NSCLC) that has spread to\n      other parts of the body."
        }, 
        "brief_title": "Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy", 
        "completion_date": {
            "#text": "April 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Lung Cancer Non-small Cell Stage IV", 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Lung Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "The investigational medicinal product denosumab is a protein (monoclonal antibody) that\n      works to slow down bone destruction caused by cancer spreading to the bone (bone\n      metastasis). Denosumab is used in adults with cancer to prevent serious complications caused\n      by bone metastasis (e.g. fracture, pressure on the spinal cord or the need to receive\n      radiation therapy or surgery). Results from one study in lung cancer patients with bone\n      metastasis suggested that adding denosumab to the standard chemotherapy may lead to a\n      possible survival benefit.\n\n      All patients will receive standard chemotherapy consisting of a combination of\n      platinum-based agents plus gemcitabine or pemetrexed, depending on the nature of the lung\n      cancer, every 3 weeks for about 3-4 months:\n\n      Patients will be assigned to one of two groups, known as 'arms'.\n\n      The treatment for each arm will be as follows:\n\n      Arm A: 4 - 6 cycles of chemotherapy and best supportive care\n\n      Arm B: 4 - 6 cycles of chemotherapy + denosumab 120 mg, administered subcutaneously every\n      3-4 weeks.\n\n      Denosumab treatment may continue thereafter until 2 years after the study has been\n      evaluated.\n\n      A total of 1000 patients from centers in Europe, Switzerland and Israel are expected to be\n      enrolled in this study over a period of 37 months.The study will take approximately 51\n      months to be completed"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Histologically or cytologically confirmed advanced stage IV non-small cell lung\n             carcinoma (NSCLC), according to 7th TNM classification\n\n          -  Age \u2265 18 years\n\n          -  ECOG performance status 0-2\n\n          -  Measurable or evaluable disease (according to RECIST 1.1 criteria)\n\n          -  Availability of tumour tissue for translational research:\n\n          -  preferred: FFPE block from primary tumour or metastasis,\n\n          -  alternatively: cell block\n\n          -  if no block available: 10 unstained slides with wax protection\n\n          -  Adequate haematological function: neutrophils \u2265 1.5 \u00d7109/L, platelets\n\n             \u2265 100\u00d7109/L, and hemoglobin \u2265 9 g/dL\n\n          -  Adequate liver function:\n\n          -  ALT \u2264 3 \u00d7 ULN ( \u2264 5 \u00d7 ULN if liver metastasis are present)\n\n          -  Total bilirubin < 2 x ULN\n\n          -  Adequate renal function: calculated creatinine clearance \u2265 30 mL/min (according to\n             the formula of Cockroft-Gault)\n\n          -  Life expectancy of at least 3 months\n\n          -  Women of childbearing potential, including women who had their last menstrual period\n             in the last 2 years, must have a negative serum or urine pregnancy test within 14\n             days before beginning treatment\n\n          -  All sexually active men and women of childbearing potential must use an effective\n             contraceptive method during the study treatment and for a period of at least 5 months\n             following the last administration of trial treatment\n\n          -  Written Informed Consent must be signed and dated by the patient and the investigator\n             prior to any trial-related intervention for\n\n               1. Trial treatment\n\n               2. Submission of biomaterial for central testing\n\n        Exclusion Criteria:\n\n          -  Patients with presence of documented sensitizing EGFR activating mutation or ALK\n             rearrangements (screening following local standards is optional, but strongly\n             encouraged in non-squamous histology)\n\n          -  Patients with documented brain metastases (systematic screening of patients not\n             mandatory)\n\n          -  Prior chemotherapy or molecular targeted therapy for metastatic disease, with the\n             exception of neoadjuvant or adjuvant chemotherapy or definitive radiochemotherapy, if\n             terminated more than 6 months before registration.\n\n          -  Any investigational agent(s) within 30 days prior to randomisation\n\n          -  Concurrent bisphosphonate administration\n\n          -  Oral/ dental conditions (by visual inspection):\n\n          -  Prior history or current evidence of osteomyelitis / osteonecrosis of the jaw\n\n          -  Active dental or jaw condition which requires oral surgery\n\n          -  Planned invasive dental procedure for the course of the trial\n\n          -  Non-healed dental or oral surgery\n\n          -  Evidence of any medical condition which would impair the ability of the patient to\n             participate in the trial or might preclude therapy with trial drugs (e.g. unstable or\n             uncompensated respiratory, cardiac, hepatic or renal disease, active infection,\n             uncontrolled diabetes mellitus; uncontrolled arterial hypertension \u2265 150/100 mmHg,\n             history of myocardial infarction in the last 3 months)\n\n          -  Documented active infection with Hepatitis B virus or Hepatitis C virus, known\n             infection with human immunodeficiency virus (HIV)\n\n          -  Known hypersensitivity to any of the components of the treatment\n\n          -  Severe, uncorrected hypocalcaemia or hypercalcaemia:\n\n          -  hypercalcaemia: total calcium >3.1 mmol/l, corrected calcium (with albumin level) >3\n             mmol/l\n\n          -  hypocalcaemia: total calcium <2 mmol/l, corrected calcium (with albumin level) < 1.9\n             mmol/l\n\n          -  Legal incapacity or limited legal capacity\n\n          -  Medical or psychological condition which in the opinion of the investigator would not\n             permit the patient to complete the trial or sign meaningful informed consent\n\n          -  Women who are pregnant or breastfeeding\n\n          -  Any concurrent malignancy other than adequately treated basal or squamous cell\n             carcinoma of the skin, in situ carcinoma of the cervix or bladder, in situ breast\n             carcinoma. (Patients with a previous malignancy but without evidence of disease for \u2265\n             2 years will be allowed to enter the trial)\n\n          -  Any previous exposure to denosumab, with the exception of a maximum of 2 previous\n             doses of denosumab (Prolia\u00ae) more than 6 month before enrolment for osteoporosis\n             treatment/prevention\n\n          -  Previous bisphosphonate exposure which:\n\n          -  exceeds 2 prior doses of i.v. bisphosphonates AND/OR\n\n          -  exceeds a cumulative exposure of 1 year oral bisphosphonates"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 30, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02129699", 
            "org_study_id": "ETOP 5-12 / EORTC 08111", 
            "secondary_id": [
                "2013-003156-21", 
                "20080166"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Standard chemotherapy + Denosumab", 
                "description": "Denosumab: 120 mg, s.c. every 3-4 weeks (in cycle 1 additional dose on day 8) until unacceptable toxicity, patient refusal or patient's death (max. 4 years 3 months).", 
                "intervention_name": "Denosumab", 
                "intervention_type": "Drug", 
                "other_name": "XGEVA"
            }, 
            {
                "arm_group_label": "None, standard chemotherapy only", 
                "description": "Possible standard chemotherapies (3 weeks cycles, duration: 4 - 6 cycles):\nCisplatin 75 mg/m2 as an infusion on day 1 Gemcitabine 1250 mg/m2 as an infusion days 1 and 8 or Carboplatin AUC 5 as an infusion on day 1 Gemcitabine 1000 mg/m2 as an infusion days 1 and 8 or Cisplatin 75 mg/m2 as an infusion on day 1 Pemetrexed 500 mg/m2 as an infusion on day 1 or Carboplatin AUC 5 as an infusion on day 1 Pemetrexed 500 mg/m2 as an infusion on day 1", 
                "intervention_name": "None, standard chemotherapy only", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "NSCLC", 
            "stage IV"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "link": {
            "description": "Sponsor", 
            "url": "http://www.etop-eu.org"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Innsbruck", 
                        "country": "Austria"
                    }, 
                    "name": "Univ. Klinik f\u00fcr Innere Medizin V"
                }, 
                "investigator": {
                    "last_name": "Georg Pall", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Linz", 
                        "country": "Austria"
                    }, 
                    "name": "KH der Elisabethinen Linz"
                }, 
                "investigator": {
                    "last_name": "Michael Schumacher", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salzburg", 
                        "country": "Austria"
                    }, 
                    "name": "LKH Salzburg"
                }, 
                "investigator": {
                    "last_name": "Michael Studnicka", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wien", 
                        "country": "Austria"
                    }, 
                    "name": "Otto-Wagner-Spital Department 1"
                }, 
                "investigator": {
                    "last_name": "Otto Burghuber", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wien", 
                        "country": "Austria"
                    }, 
                    "name": "Otto-Wagner-Spital Department 2"
                }, 
                "investigator": {
                    "last_name": "Andrea Mohn-Staudner", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Kurt Toumoy, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium"
                    }, 
                    "name": "OLV Hospital Aalst Belgium"
                }, 
                "investigator": {
                    "last_name": "Kurt Toumoy", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Surmont Veerle, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Ghent", 
                        "country": "Belgium"
                    }, 
                    "name": "University Hosptial Ghent"
                }, 
                "investigator": {
                    "last_name": "Surmont Veerle", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ingel Demendts, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Mennen", 
                        "country": "Belgium"
                    }, 
                    "name": "Heilig Hartziekenhuis Roselare"
                }, 
                "investigator": {
                    "last_name": "Ingel Demendts", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Plovdiv", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Complex Oncology Center - Plovdiv EOOD"
                }, 
                "investigator": {
                    "last_name": "Vladimir Kanarev", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sofia", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Serdika Hospital"
                }, 
                "investigator": {
                    "last_name": "Krasimir Koynow", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varna", 
                        "country": "Bulgaria"
                    }, 
                    "name": "Sveta Marina Hospital"
                }, 
                "investigator": {
                    "last_name": "Dimitar Kalev", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France"
                    }, 
                    "name": "Centre hospitalier universitaire d`Angers"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Annecy", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier Annecy"
                }, 
                "investigator": {
                    "last_name": "Manuel Cobo Dols", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier universitaire Brest"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creil", 
                        "country": "France"
                    }, 
                    "name": "GHPSO (Sie de Creil)"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier Intercommunal Creteil"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Le Mans", 
                        "country": "France"
                    }, 
                    "name": "Hospital Center Le Mans"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital du Cluzeau"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lorient", 
                        "country": "France"
                    }, 
                    "name": "CHBS Lorient"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France"
                    }, 
                    "name": "H\u00f4pital Louis Pradel"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Laurent Greillier, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France"
                    }, 
                    "name": "Assistance Publique-H\u00f4itaux de Marseille"
                }, 
                "investigator": {
                    "last_name": "Laurent Gueillier", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France"
                    }, 
                    "name": "Institut Paoli-Calmettes"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Meaux", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier de Meaux"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France"
                    }, 
                    "name": "Centre Hospitalier Universitaire Rennes"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saint-Nazaire", 
                        "country": "France"
                    }, 
                    "name": "Clinique Mutualiste de l`Estuaire"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sisteron", 
                        "country": "France"
                    }, 
                    "name": "CHICAS"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Helge Bischoff, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Heidelberg", 
                        "country": "Germany"
                    }, 
                    "name": "Thoraxklinik Heidelberg"
                }, 
                "investigator": {
                    "last_name": "Helge Bischoff, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany"
                    }, 
                    "name": "ASKLEPIOS - Fachkliniken M\u00fcnchen - Gauting"
                }, 
                "investigator": {
                    "last_name": "Joachim von Pawel", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oldenburg", 
                        "country": "Germany"
                    }, 
                    "name": "Pius Hospital"
                }, 
                "investigator": {
                    "last_name": "Frank Griesinger", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cork", 
                        "country": "Ireland"
                    }, 
                    "name": "Cork University Hospital"
                }, 
                "investigator": {
                    "last_name": "Deirdre O'Mahony", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "St James's Hospital"
                }, 
                "investigator": {
                    "last_name": "Sinead Cuffe", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "St Vincent's University Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dublin", 
                        "country": "Ireland"
                    }, 
                    "name": "The Adelaide and Meath Hospital"
                }, 
                "investigator": {
                    "last_name": "Janice Walshe", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galway", 
                        "country": "Ireland"
                    }, 
                    "name": "University Hospital Galway"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Letterkenny", 
                        "country": "Ireland"
                    }, 
                    "name": "Letterkenny General Hospital"
                }, 
                "investigator": {
                    "last_name": "Olabode Oladipo", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kfar Saba", 
                        "country": "Israel"
                    }, 
                    "name": "Meir Hospital"
                }, 
                "investigator": {
                    "last_name": "Maya Gottfried", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Petah Tikwa", 
                        "country": "Israel"
                    }, 
                    "name": "Institution Rabin MC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tel Hashomer", 
                        "country": "Israel"
                    }, 
                    "name": "Sheba Medical Center"
                }, 
                "investigator": {
                    "last_name": "Amir Onn", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tel-Aviv", 
                        "country": "Israel"
                    }, 
                    "name": "Tel-Aviv Medical Center"
                }
            }, 
            {
                "contact": {
                    "last_name": "Cesare Gridelli, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Aversa", 
                        "country": "Italy"
                    }, 
                    "name": "S.G Moscati Hospital"
                }, 
                "investigator": {
                    "last_name": "Cesare Gridelli", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Franceso Gossi, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy"
                    }, 
                    "name": "istituto Nazionale per la Ricerca sul Cancro"
                }, 
                "investigator": {
                    "last_name": "Franceso Grossi", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrea Luciani"
                }, 
                "facility": {
                    "address": {
                        "city": "Milan", 
                        "country": "Italy"
                    }, 
                    "name": "San Paolo Hospital"
                }, 
                "investigator": {
                    "last_name": "Andrea Luciani", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monza", 
                        "country": "Italy", 
                        "zip": "20900"
                    }, 
                    "name": "Ospedale San Gerardo"
                }, 
                "investigator": {
                    "last_name": "Paolo Bidoli", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dariusz Kowaski"
                }, 
                "facility": {
                    "address": {
                        "city": "Gliwice", 
                        "country": "Poland"
                    }, 
                    "name": "Maria Sklodowska-Curie Memorial Car"
                }, 
                "investigator": {
                    "last_name": "Dariusz Kowaski, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania"
                    }, 
                    "name": "Emergency University Bucharest Hospital"
                }, 
                "investigator": {
                    "last_name": "Polixenia Iorga", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania"
                    }, 
                    "name": "Institute of Oncology Bucharest Department 1"
                }, 
                "investigator": {
                    "last_name": "Dr Alexandro Grigorescu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bucharest", 
                        "country": "Romania"
                    }, 
                    "name": "Institute of Oncology Bucharest Department 2"
                }, 
                "investigator": {
                    "last_name": "Mircea Dediu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oradea", 
                        "country": "Romania"
                    }, 
                    "name": "Spitalu Judetean Oradea"
                }, 
                "investigator": {
                    "last_name": "Delia Ruta Muresan", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Tanja Cufer, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Golnik", 
                        "country": "Slovenia"
                    }, 
                    "name": "University Clinic Golnik"
                }, 
                "investigator": {
                    "last_name": "Tanja Cufer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Mirjana Rajer, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Ljubljana", 
                        "country": "Slovenia"
                    }, 
                    "name": "Institute of Oncology Ljubljana"
                }, 
                "investigator": {
                    "last_name": "Mirjana Rajer", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Alicante", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital general de Alicante"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08025"
                    }, 
                    "name": "Hospital De La Santa Creu I Sant Pau"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain"
                    }, 
                    "name": "Institut Catal\u00e0 d'Oncologia - L'Hospitalet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Castell\u00f3n", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital General Castell\u00f3n"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "C\u00f3rdoba", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Reina Sofia"
                }, 
                "investigator": {
                    "last_name": "Isidoro Barneto", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ja\u00e9n", 
                        "country": "Spain"
                    }, 
                    "name": "Complejo Hospitalario de Ja\u00e9n"
                }, 
                "investigator": {
                    "last_name": "Nuria C\u00e1rdenas Quesada", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Palmas", 
                        "country": "Spain"
                    }, 
                    "name": "H. U. Insular Gran Canaria"
                }, 
                "investigator": {
                    "last_name": "Delvys Rodriguez Abreu", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murcia", 
                        "country": "Spain"
                    }, 
                    "name": "H Morales Meseguer"
                }, 
                "investigator": {
                    "last_name": "Jose Antonio Marc\u00edas", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Palma de Mallorca", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Son Espases"
                }, 
                "investigator": {
                    "last_name": "Raquel Mars\u00e9", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Arnau Vilanova Valencia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaragoza", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitario Miguel Servet"
                }, 
                "investigator": {
                    "last_name": "Angel Artal", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bern", 
                        "country": "Switzerland", 
                        "zip": "3010"
                    }, 
                    "name": "Inselspital Bern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chur", 
                        "country": "Switzerland"
                    }, 
                    "name": "Kantonsspital Graub\u00fcnden"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fribourg", 
                        "country": "Switzerland"
                    }, 
                    "name": "HFR Fribourg"
                }, 
                "investigator": {
                    "last_name": "Daniel Betticher", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland"
                    }, 
                    "name": "Centre Hospitalier Universitaire Vaudois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Luzern", 
                        "country": "Switzerland", 
                        "zip": "6016"
                    }, 
                    "name": "Kantonsspital Luzern"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Gallen", 
                        "country": "Switzerland", 
                        "zip": "9007"
                    }, 
                    "name": "Kantonsspital St. Gallen"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Thun", 
                        "country": "Switzerland", 
                        "zip": "3600"
                    }, 
                    "name": "Onkologiezentrum Berner Oberland"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Winterthur", 
                        "country": "Switzerland", 
                        "zip": "8401"
                    }, 
                    "name": "Kantonsspital Winterthur"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Z\u00fcrich", 
                        "country": "Switzerland"
                    }, 
                    "name": "Universit\u00e4tsspital Z\u00fcrich"
                }
            }, 
            {
                "contact": {
                    "last_name": "Marianne Nicolson, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Aberdeen", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Aberdeen Royal Infirmary"
                }, 
                "investigator": {
                    "last_name": "Marianne Nicolson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Denis Talbot, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Oxford", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Oxford University Hospitals Trust"
                }, 
                "investigator": {
                    "last_name": "Denis Talbot", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Sarah Danson, MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Sheffield", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Weston Park Hospital"
                }, 
                "investigator": {
                    "last_name": "Sarah Danson, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Bulgaria", 
                "France", 
                "Germany", 
                "Ireland", 
                "Israel", 
                "Italy", 
                "Poland", 
                "Romania", 
                "Slovenia", 
                "Spain", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC", 
        "overall_contact": {
            "email": "SPLENDOUR@etop-eu.org", 
            "last_name": "Barbara Ruepp", 
            "phone": "+41 31 389 93 91"
        }, 
        "overall_official": [
            {
                "affiliation": "Trial Chair, CHUV Lausanne, Switzerland", 
                "last_name": "Solange Peters, MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "EORTC Trial Co-Chair, Royal Marden Hospital, Sutton, UK", 
                "last_name": "Mary O'Brien", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "EORTC Trial Co-Chair, University of Sheffield, Sheffield, UK", 
                "last_name": "Sarah Danson, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Trial Co-Chair, University Hospital of Zuerich, Switzerland", 
                "last_name": "Rolf Stahel, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Austria: Austrian Medicines and Medical Devices Agency", 
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Bulgaria: Bulgarian Drug Agency", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
                "Germany: Paul-Ehrlich-Institut", 
                "Ireland: Irish Medicines Board", 
                "Israel: Ministry of Health", 
                "Italy: The Italian Medicines Agency", 
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "Romania: National Agency for Medicines and Medical Devices", 
                "Slovenia: Agency for Medicinal Products - Ministry of Health", 
                "Spain: Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios", 
                "Switzerland: Swissmedic", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Defined as time from the date of randomisation until death from any cause. Patients who are still alive at last contact are censored at the date of last follow up.", 
            "measure": "Overall survival", 
            "safety_issue": "No", 
            "time_frame": "Time from the date of randomisation until death from any cause, assessed up to 51 months"
        }, 
        "reference": [
            {
                "PMID": "15197804", 
                "citation": "Rosen LS, Gordon D, Tchekmedyian NS, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, De Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman J. Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial. Cancer. 2004 Jun 15;100(12):2613-21."
            }, 
            {
                "PMID": "17451841", 
                "citation": "Tsuya A, Kurata T, Tamura K, Fukuoka M. Skeletal metastases in non-small cell lung cancer: a retrospective study. Lung Cancer. 2007 Aug;57(2):229-32. Epub 2007 Apr 23."
            }, 
            {
                "PMID": "21343556", 
                "citation": "Henry DH, Costa L, Goldwasser F, Hirsh V, Hungria V, Prausova J, Scagliotti GV, Sleeboom H, Spencer A, Vadhan-Raj S, von Moos R, Willenbacher W, Woll PJ, Wang J, Jiang Q, Jun S, Dansey R, Yeh H. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol. 2011 Mar 20;29(9):1125-32. doi: 10.1200/JCO.2010.31.3304. Epub 2011 Feb 22."
            }, 
            {
                "PMID": "21326202", 
                "citation": "Tan W, Zhang W, Strasner A, Grivennikov S, Cheng JQ, Hoffman RM, Karin M. Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling. Nature. 2011 Feb 24;470(7335):548-53. doi: 10.1038/nature09707. Epub 2011 Feb 16."
            }, 
            {
                "PMID": "23154554", 
                "citation": "Scagliotti GV, Hirsh V, Siena S, Henry DH, Woll PJ, Manegold C, Solal-Celigny P, Rodriguez G, Krzakowski M, Mehta ND, Lipton L, Garc\u00eda-S\u00e1enz JA, Pereira JR, Prabhash K, Ciuleanu TE, Kanarev V, Wang H, Balakumaran A, Jacobs I. Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study. J Thorac Oncol. 2012 Dec;7(12):1823-9. doi: 10.1097/JTO.0b013e31826aec2b."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02129699"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Progression-free survival (PFS) is defined as time from date of randomisation until objective disease progression or death, whichever occurs first. Disease progression and its evaluation are defined based on RECIST 1.1. If neither event has been observed, then the patient is censored at the date of the last follow up examination.\nPatients with new non-lung cancer malignancy must continue to be followed for progression of the original lung cancer.\nPatients who discontinue treatment prior to documented disease progression, including those who initiate non-protocol therapy prior to progression, will be followed for disease progression and death.", 
                "measure": "Progression-free survival (PFS) based on RECIST 1.1", 
                "safety_issue": "No", 
                "time_frame": "Time from date of randomisation until objective disease progression or death, whichever occurs first, assessed up to 51 months"
            }, 
            {
                "description": "For details to RECIST 1.1 criteria, see protocol appendix 2", 
                "measure": "Response based on RECIST 1.1", 
                "safety_issue": "No", 
                "time_frame": "Response of the tumour is defined according to RECIST 1.1 criteria, assessed up to 51 months"
            }, 
            {
                "description": "Toxicity profile of denosumab: Adverse events classified according to NCI CTCAE V4", 
                "measure": "Toxicity profile of denosumab", 
                "safety_issue": "Yes", 
                "time_frame": "Assessed up to 51 weeks"
            }, 
            {
                "description": "Collection of tumor material at randomisation (and highly desirable at progression) and collection of serum samples at baseline, at day 1 of cycles 3 (week 7) and at first progression", 
                "measure": "Evaluation of potential predictive biomarkers for denosumab activity", 
                "safety_issue": "No", 
                "time_frame": "Assessed at baseline, week 7 and at progression (maximum of 51 weeks)"
            }
        ], 
        "source": "European Thoracic Oncology Platform", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Amgen", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "European Thoracic Oncology Platform", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}